PIERONI, Marco
 Distribuzione geografica
Continente #
NA - Nord America 1.453
EU - Europa 1.173
AS - Asia 796
AF - Africa 32
SA - Sud America 4
OC - Oceania 2
Totale 3.460
Nazione #
US - Stati Uniti d'America 1.439
CN - Cina 390
IE - Irlanda 293
IT - Italia 290
SG - Singapore 256
SE - Svezia 225
FI - Finlandia 115
TR - Turchia 98
DE - Germania 82
AT - Austria 43
CI - Costa d'Avorio 28
CZ - Repubblica Ceca 19
FR - Francia 19
GB - Regno Unito 19
BE - Belgio 18
IN - India 16
NL - Olanda 15
KR - Corea 12
CA - Canada 9
LU - Lussemburgo 9
ES - Italia 7
HK - Hong Kong 5
PK - Pakistan 4
BR - Brasile 3
ID - Indonesia 3
PA - Panama 3
TW - Taiwan 3
UA - Ucraina 3
VN - Vietnam 3
AU - Australia 2
CH - Svizzera 2
EG - Egitto 2
GH - Ghana 2
LT - Lituania 2
MY - Malesia 2
PL - Polonia 2
SI - Slovenia 2
BG - Bulgaria 1
CL - Cile 1
CY - Cipro 1
HN - Honduras 1
HR - Croazia 1
IR - Iran 1
IS - Islanda 1
JP - Giappone 1
ME - Montenegro 1
MX - Messico 1
NO - Norvegia 1
NP - Nepal 1
PT - Portogallo 1
RU - Federazione Russa 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 3.460
Città #
Chandler 339
Dublin 291
Singapore 187
Ann Arbor 146
Ashburn 99
Parma 84
Boardman 78
Dearborn 72
Izmir 72
Shanghai 68
Nanjing 61
Beijing 57
Princeton 57
Helsinki 48
Wilmington 43
Bremen 40
Vienna 35
Abidjan 28
Chicago 26
Kocaeli 21
New York 20
San Mateo 18
Santa Clara 18
Hefei 17
Nanchang 17
Falls Church 16
Guangzhou 16
Hebei 16
Shenyang 16
Brussels 15
Milan 15
Changsha 14
Jinan 13
Seattle 13
Brno 12
Jiaxing 12
Los Angeles 12
Norwalk 12
Houston 9
Bologna 8
Dallas 8
Des Moines 8
Fremont 8
Munich 8
Dalmine 6
Sassari 6
Woodbridge 6
Birmingham 5
Fairfield 5
Istanbul 5
London 5
Luxembourg 5
Modena 5
New Brunswick 5
Ningbo 5
Brescia 4
Chongqing 4
Dordrecht 4
Haikou 4
Kunming 4
Pune 4
San Giuliano Milanese 4
Verona 4
Washington 4
Zhengzhou 4
Ahmedabad 3
Amstelveen 3
Bandung 3
Beitou 3
Edinburgh 3
Florence 3
Gonzaga 3
Grafing 3
Gwanak-gu 3
Hong Kong 3
Lucca 3
Ottawa 3
Panama City 3
Rockville 3
Rome 3
Sissa 3
Uppsala 3
Ancona 2
Angers 2
Antwerpen 2
Basel 2
Brisbane 2
Cairo 2
Carpi 2
Chengdu 2
Chiniot 2
Daejeon 2
Dong Ket 2
Dudelange 2
Evanston 2
Figline Valdarno 2
Formigine 2
Gijón 2
Hangzhou 2
Huizhou 2
Totale 2.358
Nome #
Discovery of Substituted (2-Aminooxazol-4-yl)Isoxazole-3-carboxylic Acids as Inhibitors of Bacterial Serine Acetyltransferase in the Quest for Novel Potential Antibacterial Adjuvants 147
Nuovi composti antimicrobici 143
Investigational Studies on a Hit Compound Cyclopropane-Carboxylic Acid Derivative Targeting O-Acetylserine Sulfhydrylase as a Colistin Adjuvant 109
Refining the structure−activity relationships of 2-phenylcyclopropane carboxylic acids as inhibitors of O-acetylserine sulfhydrylase isoforms 99
Discovering a new class of antifungal agents that selectively inhibits microbial carbonic anhydrases 91
Integration of Enhanced Sampling Methods with Saturation Transfer Difference Experiments to Identify Protein Druggable Pockets 91
Rational Design, Synthesis and Preliminary Structure-Activity Relationships of α-Substituted-2-Phenylcyclopropane Carboxylic Acids as Inhibitors of Salmonella Typhimurium O-Acetylserine Sulfhydrylase 86
Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design 82
Inhibition of Nonessential Bacterial Targets: Discovery of a Novel Serine O-Acetyltransferase Inhibitor 79
Antituberculosis agents: Beyond medicinal chemistry rules 77
A competitive o‐acetylserine sulfhydrylase inhibitor modulates the formation of cysteine synthase complex 77
Exploring the chemical space around N-(5-nitrothiazol-2-yl)-1,2,3-thiadiazole-4-carboxamide, a hit compound with serine acetyltransferase (SAT) inhibitory properties 76
Inhibitors of the sulfur assimilation pathway in bacterial pathogens as enhancers of antibiotic therapy 76
Aspergillus fumigatus tryptophan metabolic route differently affects host immunity 73
Cyclopropane derivatives as potential human serine racemase inhibitors: unveiling novel insights into a difficult target 72
Sodium Hyaluronate Nanocomposite Respirable Microparticles to Tackle Antibiotic Resistance with Potential Application in Treatment of Mycobacterial Pulmonary Infections 71
Blocking cysteine biosynthesis in Salmonella typhimurium: the moonlighting enzyme CysK as a potential antibiotic target 70
Inhibitors of O-Acetylserine Sulfhydrylase with a Cyclopropane-Carboxylic Acid Scaffold Are Effective Colistin Adjuvants in Gram Negative Bacteria 68
Cycloserine enantiomers are reversible inhibitors of human alanine:glyoxylate aminotransferase: Implications for Primary Hyperoxaluria type 1 68
Modulation of bacterial metabolism by the microenvironment controls MAIT cell stimulation 68
Cyclopropane-1,2-dicarboxylic acids as new tools for the biophysical investigation of O-acetylserine sulfhydrylases by fluorimetric methods and saturation transfer difference (STD) NMR 64
Design, Synthesis and Investigation onthe Structure–Activity Relationships of N-Substituted 2-Aminothiazole Derivatives as Antitubercular Agents 63
Accepting the Invitation to Open Innovation in Malaria Drug Discovery: Synthesis, Biological Evaluation, and Investigation on the Structure-Activity Relationships of Benzo[b]thiophene-2-carboxamides as Antimalarial Agents 62
Discovery of Multitarget Agents Active as Broad-Spectrum Antivirals and Correctors of Cystic Fibrosis Transmembrane Conductance Regulator for Associated Pulmonary Diseases 62
Crystal structure of Aspergillus fumigatus AroH, an aromatic amino acid aminotransferase 61
Discovery of novel fragments inhibiting O-acetylserine sulphhydrylase by combining scaffold hopping and ligand–based drug design 60
Substituted N-Phenyl-5-(2-(phenylamino)thiazol-4-yl)isoxazole-3-carboxamides Are Valuable Antitubercular Candidates that Evade Innate Efflux Machinery 59
Adjuvant therapies against tuberculosis: discovery of a 2-aminothiazole targeting Mycobacterium tuberculosis energetics 58
Further insights into the SAR of α-substituted cyclopropylamine derivatives as inhibitors of histone demethylase KDM1A 58
In vitro digestion of zingiber officinale extract and evaluation of stability as a first step to determine its bioaccesibility 57
Sodium Hyaluronate Microparticles for Pulmonary Delivery of Anti-mycobacterial Drugs 55
Towards the sustainable discovery and development of new antibiotics 53
Challenging the drug-likeness dogma for new drug discovery in Tuberculosis 50
Derivatives of 3-isoxazolecarboxylic acid esters - a potent and selective compound class against replicating and nonreplicating Mycobacterium tuberculosis 49
A combined ligand- and structure-based approach for the identification of rilmenidine-derived compounds which synergize the antitumor effects of doxorubicin 49
2-Aminooxazole as a Novel Privileged Scaffold in Antitubercular Medicinal Chemistry 49
Preliminary structure - Activity relationships and biological evaluation of novel antitubercular indolecarboxamide derivatives against drug-susceptible and drug-resistant Mycobacterium tuberculosis strains 48
6-Hydrogen-8-Methylquinolones Active Against Replicating and Non-replicating Mycobacterium tuberculosis 48
Biochemical characterization of Aspergillus fumigatus AroH, a putative aromatic amino acid aminotransferase 48
Discovery of New Potential Anti-Infective Compounds Based on Carbonic Anhydrase Inhibitors by Rational Target-Focused Repurposing Approaches 47
Identification of Human Alanine-Glyoxylate Aminotransferase Ligands as Pharmacological Chaperones for Variants Associated with Primary Hyperoxaluria Type 1 44
Modulation of bacterial metabolism by the microenvironment controls MAIT cell stimulation article 43
Synthesis of 7-desmethyl analogs of (+)- and (-)-huperzine A 42
Nitric oxide-releasing cyclodextrins as biodegradable antibacterial scaffolds: a patent evaluation of US2019343869(A1) 42
From 6-aminoquinolone antibacterials to 6-amino-7- thiopyranopyridinylquinolone ethyl esters as inhibitors of staphylococcus aureus multidrug efflux pumps 40
Rational Design and Synthesis of Thioridazine Analogues as Enhancers of the Antituberculosis Therapy 40
Structural analogs of huperzine A improve survival in guinea pigs exposed to soman 38
An Experimental Model for the Rapid Screening of Compounds with Potential Use Against Mycobacteria 37
Expanding the knowledge around antitubercular 5-(2-aminothiazol-4-yl)isoxazole-3-carboxamides: Hit–to–lead optimization and release of a novel antitubercular chemotype via scaffold derivatization 34
Indoleamides are active against drug-resistant mycobacterium tuberculosis 32
Pyrido[1,2-a]benzimidazole-Based Agents Active Against Tuberculosis (TB), Multidrug-Resistant (MDR) TB and Extensively Drug-Resistant (XDR) TB 31
Synthesis and Structure-Activity Relationships of Lansine Analogues as Antileishmanial Agents 31
NOC chemistry for tuberculosis - Further investigations on the structure-activity relationships of antitubercular isoxazole-3-carboxylic acid ester derivatives 31
Efflux Activity Differentially Modulates the Levels of Isoniazid and Rifampicin Resistance among Multidrug Resistant and Monoresistant Mycobacterium tuberculosis Strains 30
Searching for innovative quinolone-like scaffolds: Synthesis and biological evaluation of 2,1-benzothiazine 2,2-dioxide derivatives 28
From serendipity to rational antituberculosis drug discovery of mefloquine-isoxazole carboxylic acid esters 28
Spectinamides: A challenge, a proof, and a suggestion 27
Novel N-benzoyl-2-hydroxybenzamide disrupts unique parasite secretory pathway 27
Synthesis, biological evaluation, and structure-activity relationships of N -benzoyl-2-hydroxybenzamides as agents active against P. falciparum (K1 strain), trypanosomes, and leishmania 27
Mutation of Rv2887, a marR-Like gene, confers mycobacterium tuberculosis resistance to an imidazopyridine-based agent 26
In pursuit of natural product leads: Synthesis and biological evaluation of 2-[3-hydroxy-2-[(3-hydroxypyridine-2-carbonyl)amino]phenyl]benzoxazole-4- carboxylic acid (A-33853) and its analogues: Discovery of N-(2-benzoxazol-2- ylphenyl)benzamides as novel antileishmanial chemotypes 25
Rational design of 5-phenyl-3-isoxazolecarboxylic acid ethyl esters as growth inhibitors of Mycobacterium tuberculosis. A potent and selective series for further drug development 23
Synthesis, biological evaluation, and structure-activity relationships for 5-[(E)-2-arylethenyl]-3-isoxazolecarboxylic acid alkyl ester derivatives as valuable antitubercular chemotypes 22
Preliminary structure−activity relationships analysis on N-(3,5-dichlorophenyl)-4,5-dihydronaphtho[1,2-d]thiazol-2-amine, a disruptor of mycobacterial energetics 21
Chemical Probes to Investigate Central Nervous System Disorders: Design, Synthesis and Mechanism of Action of a Potent Human Serine Racemase Inhibitor 19
Totale 3.611
Categoria #
all - tutte 17.013
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.013


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020271 0 0 0 0 42 74 47 8 27 49 17 7
2020/2021201 3 5 8 10 6 12 8 24 46 41 17 21
2021/2022379 15 28 25 25 10 38 20 26 35 22 21 114
2022/20231.261 118 138 79 100 146 149 7 65 374 15 41 29
2023/2024507 24 40 17 28 49 72 48 44 26 28 40 91
2024/2025452 64 90 144 95 59 0 0 0 0 0 0 0
Totale 3.611